| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | 0.089 | 0.07 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.058 | 0.07 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.059 | 0.07 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.052 | 0.08 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.09 |
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | 0.082 | 0.09 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | 0.056 | 0.09 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.053 | 0.09 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | -0.052 | 0.09 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.058 | 0.1 |